Good morning, everyone, and welcome to ANI's First Quarter 2019 Earnings Call. (Operator Instructions) Please note, this call may be recorded. It is now my pleasure to turn today's program over to Mr.

Though ANI Pharmaceuticals’s net revenue grew $5 million in 2019, the company logged a nearly $24 million increase in spending. According to ANI’s annual report released Thursday, the company logged ...

ANI has grown its revenue and non-GAAP EBITDA annually since becoming a public company in 2013. We expect that trend to continue in 2019. In an increasingly competitive generic industry, we remain ...